Position in NVS
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$1,616,096
-$85,080 QoQ
Shares Held
10,312
-7.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#485
of 1,603 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kentucky Trust Co holds $15,347,264 across 11 Drug Manufacturers - General names. NVS ranks #3 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
20,789 | $5,279,782 | |
| 2 | AMGN |
Amgen Inc
|
4,717 | $1,708,120 | |
| 3 | NVS |
Novartis AG
This page
|
10,312 | $1,616,096 | |
| 4 | PFE |
Pfizer Inc
|
65,411 | $1,575,096 | |
| 5 | ABBV |
AbbVie Inc.
|
5,369 | $1,351,055 | |
| 6 | MRK |
Merck & Co., Inc.
|
10,078 | $1,295,023 | |
| 7 | LLY |
ELI LILLY & Co
|
1,023 | $1,227,016 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,378 | $713,220 |
All Filings in NVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,616,096 | 10,312 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $1,701,176 | 11,137 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $1,673,328 | 12,137 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,569,272 | 12,237 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $1,480,799 | 12,237 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $1,364,180 | 12,237 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $1,190,782 | 12,237 | Shares | Sole | 2025-01-29 | |
| No filing history on record for this holder in this stock. | ||||||